Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -16.80 |
| peg ratio | 2.40 |
| price to book ratio | 56.23 |
| price to sales ratio | 15.54 |
| enterprise value multiple | -17.94 |
| price fair value | 56.23 |
profitability ratios | |
|---|---|
| gross profit margin | 90.55% |
| operating profit margin | -90.84% |
| pretax profit margin | -91.97% |
| net profit margin | -91.87% |
| return on assets | -55.38% |
| return on equity | -234.35% |
| return on capital employed | -84.18% |
liquidity ratio | |
|---|---|
| current ratio | 2.44 |
| quick ratio | 2.37 |
| cash ratio | 1.67 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 162.72 |
| operating cycle | 296.55 |
| days of payables outstanding | 732.93 |
| cash conversion cycle | -436.38 |
| receivables turnover | 2.73 |
| payables turnover | 0.50 |
| inventory turnover | 2.24 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.34 |
| debt equity ratio | 2.07 |
| long term debt to capitalization | 0.66 |
| total debt to capitalization | 0.67 |
| interest coverage | -60.75 |
| cash flow to debt ratio | -0.69 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.75 |
| cash per share | 6.80 |
| operating cash flow per share | -2.75 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.69 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -18,938.57 |
Frequently Asked Questions
Axsome Therapeutics, Inc. (AXSM) published its most recent earnings results on 12-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Axsome Therapeutics, Inc. (NASDAQ:AXSM)'s trailing twelve months ROE is -234.35%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Axsome Therapeutics, Inc. (AXSM) currently has a ROA of -55.38%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
AXSM reported a profit margin of -91.87% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.44 in the most recent quarter. The quick ratio stood at 2.37, with a Debt/Eq ratio of 2.07.